메뉴 건너뛰기




Volumn 12, Issue , 2012, Pages

Adverse drug reactions to antiretroviral therapy (ARVs): Incidence, type and risk factors in Nigeria

Author keywords

ADR; Adverse drug reactions; Antiretroviral; HIV AIDS; Incidence; Nigeria; Risk factors; Stavudine; Tenofovir; Zidovudine

Indexed keywords

EFAVIRENZ; LAMIVUDINE PLUS STAVUDINE; LAMIVUDINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE; ADENINE; ANTIRETROVIRUS AGENT; BENZOXAZINE DERIVATIVE; DRUG DERIVATIVE; LAMIVUDINE; PHOSPHONIC ACID DERIVATIVE; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

EID: 84857426967     PISSN: None     EISSN: 14726904     Source Type: Journal    
DOI: 10.1186/1472-6904-12-7     Document Type: Article
Times cited : (51)

References (39)
  • 2
    • 0033537620 scopus 로고    scopus 로고
    • Improved survival among HIV infected patients after initiation of triple drug antiretroviral regimens
    • 1230111, 10102000
    • Hogg RS, Yip B, Kully C, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS. Improved survival among HIV infected patients after initiation of triple drug antiretroviral regimens. CMAJ 1999, 160(Suppl 5):659-665. 1230111, 10102000.
    • (1999) CMAJ , vol.160 , Issue.SUPPL. 5 , pp. 659-665
    • Hogg, R.S.1    Yip, B.2    Kully, C.3    Craib, K.J.4    O'Shaughnessy, M.V.5    Schechter, M.T.6    Montaner, J.S.7
  • 3
    • 2642709177 scopus 로고    scopus 로고
    • Declining morbidity and mortality among patients with advanced human imunodeficiency virus infection. HIV outpatient Study Investigators
    • 10.1056/NEJM199803263381301, 9516219
    • Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human imunodeficiency virus infection. HIV outpatient Study Investigators. N Engl J Med 1998, 338:853-860. 10.1056/NEJM199803263381301, 9516219.
    • (1998) N Engl J Med , vol.338 , pp. 853-860
    • Palella, F.J.1    Delaney, K.M.2    Moorman, A.C.3    Loveless, M.O.4    Fuhrer, J.5    Satten, G.A.6    Aschman, D.J.7    Holmberg, S.D.8
  • 4
    • 3242793170 scopus 로고    scopus 로고
    • Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV infected adults initiating protease inhibitor containing therapy
    • Antiprotease Cohort (APROCO) Study Group
    • Duval X, Journot V, Leport C, Chêne G, Dupon M, Cuzin L, May T, Morlat P, Waldner A, Salamon R, Raffi F, . Antiprotease Cohort (APROCO) Study Group Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV infected adults initiating protease inhibitor containing therapy. Infectious Dis Soc Am 2004, 39:248-255. Antiprotease Cohort (APROCO) Study Group.
    • (2004) Infectious Dis Soc Am , vol.39 , pp. 248-255
    • Duval, X.1    Journot, V.2    Leport, C.3    Chêne, G.4    Dupon, M.5    Cuzin, L.6    May, T.7    Morlat, P.8    Waldner, A.9    Salamon, R.10    Raffi, F.11
  • 6
    • 77954630522 scopus 로고    scopus 로고
    • Early versus standard antiretroviral therapy for HIV infected adults in Haiti
    • 10.1056/NEJMoa0910370, 20647201
    • Patrice S, Juste MA, Ambroise A, Eliacin L, et al. Early versus standard antiretroviral therapy for HIV infected adults in Haiti. N Engl J Med 2010, 363:257-265. 10.1056/NEJMoa0910370, 20647201.
    • (2010) N Engl J Med , vol.363 , pp. 257-265
    • Patrice, S.1    Juste, M.A.2    Ambroise, A.3    Eliacin, L.4
  • 7
    • 12944265462 scopus 로고    scopus 로고
    • Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study
    • 10.1097/00126334-200003010-00004, 10839659
    • Bonfanti P, Valsecchi L, Parazzini F, Carradori S, Pusterla L, et al. Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study. JAIDS 2000, 23:236-245. 10.1097/00126334-200003010-00004, 10839659.
    • (2000) JAIDS , vol.23 , pp. 236-245
    • Bonfanti, P.1    Valsecchi, L.2    Parazzini, F.3    Carradori, S.4    Pusterla, L.5
  • 9
    • 84859433967 scopus 로고    scopus 로고
    • Pharmacovigilance for antiretrovirals in resource poor countries. medicines policy and standards
    • World Health Organization
    • World Health Organization Pharmacovigilance for antiretrovirals in resource poor countries. medicines policy and standards. Geneva, World Health Organization 2007, World Health Organization.
    • (2007) Geneva, World Health Organization
  • 11
    • 0032419597 scopus 로고    scopus 로고
    • Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection
    • 10.1016/S0149-2918(98)80105-7, 9916603
    • Pollard RB, Robinson P, Dransfield K. Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. Clin Ther 1998, 20:1071-1092. 10.1016/S0149-2918(98)80105-7, 9916603.
    • (1998) Clin Ther , vol.20 , pp. 1071-1092
    • Pollard, R.B.1    Robinson, P.2    Dransfield, K.3
  • 12
    • 77952822874 scopus 로고    scopus 로고
    • Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents
    • (DHHS), U. S. D. o. H. a. H. S
    • (DHHS), U. S. D. o. H. a. H. S Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Panel on antiretroviral guidelines for adults and adolescents 2006, (DHHS), U. S. D. o. H. a. H. S.
    • (2006) Panel on antiretroviral guidelines for adults and adolescents
  • 16
    • 34147115624 scopus 로고    scopus 로고
    • Antiretroviral associated toxicity among HIV 1 seropositive pregnant women in Mozambique receiving nevirapine based regimens
    • Jamisse L, Balkus J, Hitti J, Gloyd S, Manuel R, Osman N, Djedje M, Farquhar C. Antiretroviral associated toxicity among HIV 1 seropositive pregnant women in Mozambique receiving nevirapine based regimens. J Acquir Immune Defic Syndr 2007, 44(Suppl 4):371-376.
    • (2007) J Acquir Immune Defic Syndr , vol.44 , Issue.SUPPL. 4 , pp. 371-376
    • Jamisse, L.1    Balkus, J.2    Hitti, J.3    Gloyd, S.4    Manuel, R.5    Osman, N.6    Djedje, M.7    Farquhar, C.8
  • 18
    • 1542327563 scopus 로고    scopus 로고
    • Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors
    • Dieterich DT, Love J, Stern JO. Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors. Clin Infect Dis 2004, 38(Suppl 2):S80-S89.
    • (2004) Clin Infect Dis , vol.38 , Issue.SUPPL. 2
    • Dieterich, D.T.1    Love, J.2    Stern, J.O.3
  • 19
    • 1842614923 scopus 로고    scopus 로고
    • Hepatotoxicity associated with nevirapine use
    • 10.1097/00126334-200404150-00014, 15021321
    • Baylor MS, Johann-Liang R. Hepatotoxicity associated with nevirapine use. J Acquir Immune Defic Syndr 2004, 35:538. 10.1097/00126334-200404150-00014, 15021321.
    • (2004) J Acquir Immune Defic Syndr , vol.35 , pp. 538
    • Baylor, M.S.1    Johann-Liang, R.2
  • 20
    • 0141681334 scopus 로고    scopus 로고
    • A comprehensive hepatic safety analysis of nevirapine in different populations of HIV-infected patients
    • 10.1097/00126334-200309011-00005, 14562855
    • Stern JO, Robinson PA, Love J, Lanes S, Imperiale MS, Mayers DL. A comprehensive hepatic safety analysis of nevirapine in different populations of HIV-infected patients. J Acquir Immune Defic Syndr 2003, 34:S21-S33. 10.1097/00126334-200309011-00005, 14562855.
    • (2003) J Acquir Immune Defic Syndr , vol.34
    • Stern, J.O.1    Robinson, P.A.2    Love, J.3    Lanes, S.4    Imperiale, M.S.5    Mayers, D.L.6
  • 21
    • 0242333213 scopus 로고    scopus 로고
    • Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine containing antiretroviral treatment
    • 10.1097/00002030-200310170-00009, 14523278
    • de Maat MM, ter Heine R, van Gorp EC, Mulder JW, Mairuhu AT, Beijnen JH. Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine containing antiretroviral treatment. AIDS 2003, 17:2209-2214. 10.1097/00002030-200310170-00009, 14523278.
    • (2003) AIDS , vol.17 , pp. 2209-2214
    • de Maat, M.M.1    ter Heine, R.2    van Gorp, E.C.3    Mulder, J.W.4    Mairuhu, A.T.5    Beijnen, J.H.6
  • 23
    • 84859426150 scopus 로고    scopus 로고
    • Hepatotoxicity associated with nevirapine or efavirenz containing antiretroviral therapy:role of hepatitis C and B infections
    • Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Hepatotoxicity associated with nevirapine or efavirenz containing antiretroviral therapy:role of hepatitis C and B infections. Hepatology 2003, 1:35.
    • (2003) Hepatology , vol.1 , pp. 35
    • Sulkowski, M.S.1    Thomas, D.L.2    Mehta, S.H.3    Chaisson, R.E.4    Moore, R.D.5
  • 24
    • 77952951784 scopus 로고    scopus 로고
    • The necessity for a health systems reform in Nigeria
    • Asuzu MC. The necessity for a health systems reform in Nigeria. J Community Med & Primary Health Care 2000, 16:1-3.
    • (2000) J Community Med & Primary Health Care , vol.16 , pp. 1-3
    • Asuzu, M.C.1
  • 25
    • 84892515307 scopus 로고    scopus 로고
    • National guidelines for HIV/AIDS treatment and care in adolescents and adults
    • Federal Ministry of Health Abuja, Nigeria
    • Federal Ministry of Health Abuja, Nigeria National guidelines for HIV/AIDS treatment and care in adolescents and adults. 2010, Federal Ministry of Health Abuja, Nigeria.
    • (2010)
  • 26
    • 84866663748 scopus 로고    scopus 로고
    • Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach
    • (accessed December 3rd, 2011), World Health Organization
    • World Health Organization Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. WHO 2006, 28. (accessed December 3rd, 2011), World Health Organization., http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf
    • (2006) WHO , pp. 28
  • 27
    • 84859423275 scopus 로고    scopus 로고
    • Assuring safety of preventive chemotherapy interventions for neglected tropical diseases. practical advice for national programme managers on the prevention, detection and management of serious adverse effects
    • (accessed December 3rd, 2011), World Health Organization
    • World Health Organization Assuring safety of preventive chemotherapy interventions for neglected tropical diseases. practical advice for national programme managers on the prevention, detection and management of serious adverse effects. WHO 2011, 1. (accessed December 3rd, 2011), World Health Organization., http://whqlibdoc.who.int/publications/2011/9789241502191_eng.pdf
    • (2011) WHO , pp. 1
  • 28
    • 77649173768 scopus 로고
    • Longitudinal data analysis using generalized linear models
    • Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrica 1986, 73:13-22.
    • (1986) Biometrica , vol.73 , pp. 13-22
    • Liang, K.Y.1    Zeger, S.L.2
  • 29
    • 0027217429 scopus 로고
    • Regression analysis for correlated data
    • Liang KY, Zeger SL. Regression analysis for correlated data. Annu Rev Publ Health 1993, 14:43-68.
    • (1993) Annu Rev Publ Health , vol.14 , pp. 43-68
    • Liang, K.Y.1    Zeger, S.L.2
  • 30
    • 84859433970 scopus 로고    scopus 로고
    • Glomerular dysfunction and associated risk factors following initiation of ART in adults with HIV infection in Africa [abstract THAB0105]
    • Reid A, Walker S, Ssali F, Munderi P, Gilks C. Glomerular dysfunction and associated risk factors following initiation of ART in adults with HIV infection in Africa [abstract THAB0105]. International AIDS Society 2006,
    • (2006) International AIDS Society
    • Reid, A.1    Walker, S.2    Ssali, F.3    Munderi, P.4    Gilks, C.5
  • 33
    • 0036545789 scopus 로고    scopus 로고
    • A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients
    • Idoko JA, Akinsete L, Abalaka AD, Keshinro LB, Dutse L, Onyenekwe B, Lhekwaba A, Njoku OS, Kehinde MO, Wambebe CO. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients. West Afr J Med 2002, 21:83-86.
    • (2002) West Afr J Med , vol.21 , pp. 83-86
    • Idoko, J.A.1    Akinsete, L.2    Abalaka, A.D.3    Keshinro, L.B.4    Dutse, L.5    Onyenekwe, B.6    Lhekwaba, A.7    Njoku, O.S.8    Kehinde, M.O.9    Wambebe, C.O.10
  • 35
    • 33748125363 scopus 로고    scopus 로고
    • Adverse effects of antiretroviral therapy in HIV-1 infected children
    • Shah I. Adverse effects of antiretroviral therapy in HIV-1 infected children. J Trop Pediatr 2006, 52:244-248.
    • (2006) J Trop Pediatr , vol.52 , pp. 244-248
    • Shah, I.1
  • 37
    • 79952297768 scopus 로고    scopus 로고
    • Renal safety of tenofovir containing first line regimen: experience from an antiretroviral cohort in rural Lesotho
    • 3047584, 21407815
    • Bygrave H, Kranzer K, Hilderbrand K, Jouquet G, Goemaere E, Vlahakis N, Triviño L, Makakole L, Ford N. Renal safety of tenofovir containing first line regimen: experience from an antiretroviral cohort in rural Lesotho. PLoS One 2011, 6(Suppl 3):e17609. 3047584, 21407815.
    • (2011) PLoS One , vol.6 , Issue.SUPPL. 3
    • Bygrave, H.1    Kranzer, K.2    Hilderbrand, K.3    Jouquet, G.4    Goemaere, E.5    Vlahakis, N.6    Triviño, L.7    Makakole, L.8    Ford, N.9
  • 38
    • 0033587510 scopus 로고    scopus 로고
    • Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions
    • Lucas GM, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med 1999, 131(Suppl 2):81-87.
    • (1999) Ann Intern Med , vol.131 , Issue.SUPPL. 2 , pp. 81-87
    • Lucas, G.M.1    Moore, R.D.2
  • 39
    • 57149111224 scopus 로고    scopus 로고
    • Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programs in resource-limited settings
    • Forster M, Bailey C, Brinkhof MWG. Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programs in resource-limited settings. Bull World Health Organization 2008, 86:939-947.
    • (2008) Bull World Health Organization , vol.86 , pp. 939-947
    • Forster, M.1    Bailey, C.2    Brinkhof, M.W.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.